Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

A Study to Evaluate the Efficacy, Safety, and Tolerability of E2086 Compared to Placebo and Active Comparator in Adult Participants With Narcolepsy Type 1

ClinicalTrials.gov ID: NCT06462404

Public ClinicalTrials.gov record NCT06462404. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 10:22 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Single-Dose, 5-Period Crossover Study to Evaluate the Efficacy, Safety, and Tolerability of E2086 Compared to Placebo and Active Comparator in Adult Subjects With Narcolepsy Type 1

Study identification

NCT ID
NCT06462404
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Eisai Inc.
Industry
Enrollment
22 participants

Conditions and interventions

Interventions

  • E2086 Drug
  • E2086 Placebo Drug
  • Active Comparator Drug
  • Active Comparator Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 19, 2024
Primary completion
Mar 16, 2025
Completion
Mar 16, 2025
Last update posted
Jun 3, 2025

2024 – 2025

United States locations

U.S. sites
12
U.S. states
8
U.S. cities
12
Facility City State ZIP Site status
SDS Clinical Trials Santa Ana California 48911
PharmaDev Clinical Research Miami Florida 33126
Sleep Practioners, LLC Macon Georgia 31210
Clinical Research Institute Stockbridge Georgia 30281
Sound Asleep Research, Inc. Lansing Michigan 48911
Research Carolina Elite Denver North Carolina 28037
Medical Care Inc. Goldsboro North Carolina 27534
Advances Repiratory and Sleep Medicine Greensboro North Carolina 27410
Intrepid Research, LLC Cincinnati Ohio 45245
Bogan Sleep Consultants, LLC Columbia South Carolina 29201
Sleep Therapy and Research Center San Antonio Texas 78229
Comprehensive Sleep Medicine Associates Sugar Land Texas 77478

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06462404, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 3, 2025 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06462404 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →